The Limited Times

Now you can see non-English news...

Covid-19: AstraZeneca takes a break from clinical trials of its vaccine

2020-09-09T04:51:14.989Z

Partner of the British University Oxford, the pharmaceutical group made this decision after the appearance of a "potential disease.



“As part of the University of Oxford's global randomized clinical trials of the coronavirus vaccine, our normal assessment process was triggered and we voluntarily paused vaccinations to allow for an assessment of the safety data by an independent committee ”.

It is with this press release that the pharmaceutical group AstraZeneca announced on Tuesday a pause in clinical trials of its experimental vaccine against Covid-19.

In question?

The onset of a “potentially unexplained illness”, possibly a serious side effect, in a participant.

READ ALSO>

Vaccine against Covid-19: 7 questions to understand everything


AstraZeneca is the industrial partner of the UK University of Oxford, and their vaccine is one of the most advanced Western projects, tested on tens of thousands of volunteers in the UK, Brazil, South Africa and since August 31, the United States, in what is called phase 3 of the trials, the last, to verify safety and efficacy.

Hundreds of millions of doses already pre-sold

"It is a routine action that is required as soon as a potentially unexplained disease appears in one of the trials, during the investigation, in order to maintain the integrity of the trials," continued the spokesperson for the company in this release.

The nature and severity of the event is unknown but, according to the Statnews website, the affected person should recover.

This is the first known suspension of a clinical trial concerning an experimental vaccine against Covid-19.

READ ALSO>

Vaccine against Covid-19: "Convincing the French will be a big headache"


Depending on the length of the investigations, this could have an impact on the tight development schedule.

The British Minister of Health had said on Monday that he hoped for results from AstraZeneca's trials by the end of the year or the beginning of 2021. The laboratory has already pre-sold hundreds of millions of doses to multiple countries, in case his vaccine proves its effectiveness.

Source: leparis

All life articles on 2020-09-09

You may like

Trends 24h

Latest

© Communities 2019 - Privacy